Hebei Huaweiman Pharmaceutical

Hebei Huaweiman Pharmaceutical is a specialized pharmaceutical manufacturer headquartered in Shijiazhuang, Hebei Province, China. The company focuses on the research, development, and production of active pharmaceutical ingredients (APIs) and finished oral solid dosage forms, with a particular emphasis on antiviral and cardiovascular therapeutic areas. Its product portfolio includes key generic treatments for chronic Hepatitis B, such as Entecavir and Tenofovir Disoproxil Fumarate, as well as lipid-lowering agents like Rosuvastatin. Hebei Huaweiman operates modern, GMP-certified facilities and serves as a reliable supplier for both domestic and global pharmaceutical markets. The company is recognized for its technical expertise in chemical synthesis and its commitment to providing affordable, high-quality generic medications.